Bartesian is a premium cocktail system that crafts over 16 classic and signature cocktails at the touch of a button. The Bartesian cocktail maker provides an effortless way to enjoy bar-quality cocktails at home, using real juices, bitters, and extracts from single-serve capsules. With smart technology that analyzes each capsule and customizable drink strength settings, Bartesian differentiates itself in the home cocktail market by offering convenience and quality. The company has gained traction as the world's top-selling cocktail system, appealing to cocktail enthusiasts and casual drinkers alike.
Dutch is the leading online veterinary telehealth service that connects pet parents with licensed veterinarians for quick and convenient care. The company specializes in treating common pet ailments such as anxiety and allergies, providing same-day access to licensed vets through video chat and messaging. Dutch offers membership plans that include unlimited vet visits, follow-ups, and prescription delivery, making veterinary care more accessible and affordable. With over 400,000 members and significant savings compared to traditional vet visits, Dutch is positioned as a leader in the pet telehealth market, focusing on evidence-based treatment plans tailored to individual pet needs.
FabFitFun offers subscription services that allow its members to discover brands and products. FabFitFun is a team of self-starters, working together to achieve their mission. It’s a fast-paced environment, but they always take the time to celebrate birthdays, big wins, and cheer each other on. abFitFun was founded in 2010 and is backed by tier-one investors, including New Enterprise Associates, Upfront Ventures, and Simon Venture Group.
Outcomes4Me is an AI-driven platform that empowers cancer patients by providing personalized treatment options and integrating with the NCCN Clinical Practice Guidelines. The company aims to democratize healthcare by giving patients access to evidence-based clinical information, enabling them to make informed decisions about their care. With a focus on improving health outcomes, Outcomes4Me collaborates with oncology care providers and life sciences to enhance patient access to innovative treatments and clinical trials. The platform is designed to help patients navigate their cancer journey effectively, ensuring they receive the best possible care and support.
Public is an investing platform that makes building a multi-asset portfolio fast, frictionless, and secure. Members can trade stocks, options, bonds, crypto, ETFs, and alternative assets—all in one place. Alongside its robust suite of investing tools, Public offers Alpha, a layer of Artificial Intelligence that provides fundamental data and custom analysis to support informed investment decisions. Since 2019, Public has raised over $300 million. Investors include Accel, Tiger Global, Will Smith's Dreamers VC, The Chainsmokers' Mantis VC, and Shari Redstone's Advancit Capital, as well as renowned figures in business and culture, like Maria Sharapova, Tony Hawk, and NYU Stern Professor Scott Galloway. Member questions: support@public.com Disclosures: http://public.com/disclosures
Smalls is a direct-to-consumer pet food company that specializes in human-grade, fresh cat food. The company differentiates itself by offering ultra-high protein meals without fillers, preservatives, or artificial ingredients, catering to the natural dietary needs of cats. Smalls provides a personalized meal plan based on a quick quiz, ensuring that each cat receives the nutrition it requires. With a strong emphasis on health benefits, 88% of customers report improvements in their cats' health after switching to Smalls. Founded in 2017, Smalls has gained traction in the pet food market, positioning itself as a healthier alternative to traditional pet food brands.
Thirty Madison exists to deliver on healthcare's biggest opportunities: access and affordability; patient outcomes; and patient experience. With empathy at the heart of its innovation, its proprietary care model empowers hundreds of thousands of people with ongoing conditions with accessible, effective treatments across a lifetime of care.